Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Synthetic Genomics, Janssen Ink RNA Technology Agreement | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

Synthetic Genomics, Janssen Ink RNA Technology Agreement

To apply replicon RNA technology for the design and development of medicines for infectious diseases

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Synthetic Genomics, Inc. has entered a research and licensing option agreement with Janssen Vaccines & Prevention B.V., to apply its replicon RNA technology for the design and development of novel RNA-based medicines for infectious diseases. The agreement was facilitated by Johnson & Johnson Innovation. 
 
Synthetic Genomics replicon RNA technology enables a tunable, multigenic approach to elicit desired antigen expression and immune response for a variety of applications. The company believes that this technology will enable the development of RNA-based therapies and vaccines that enhance and fine tune immune response against infectious diseases and cancer.
 
“Our replicon RNA platform is designed to enable controlled expression of antigens and therapeutic proteins to elicit effective immune response against diseases that have historically been difficult to treat or prevent,” said Oliver Fetzer, Ph.D., chief executive officer of Synthetic Genomics. “Our expertise in programming viral systems to improve upon natural biological processes is uniquely suited to the aspirations of this collaboration with Janssen.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics